Taiwan Biomaterial Co., Ltd.

NT$34.50As of Sun 8 Nov 2026, 12:00 UTC
TPEx:6649Healthcare
Country Taiwan
PE (Fwd) •••
TSR 9Y CAGR (7.80%)
Div yield 2.90%
ROE 1.21%
Medical Devices
Beta (5Y) 0.39
PE TTM 185.3
TSR TTM (46.41%)
Mkt cap NT$1.449B
ROIC (1.66%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$40
15.89%
(8.62%)
Sell 1|11|1|8|12
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.47
0.50
0.54
0.52
(5.19%)
(0.99%)
8.84%
8.56%
RevenueNT$M
96.02
101.2
100.8
106.3
4.91%
6.91%
6.20%
11.30%
Peers (US$43.76M)
Cap (US$)
PE
40.82M
5.838x
37.57M
11.30x
36.43M
—
43.77M
—
Capital
TTM
5Y
10Y
Leveragex
1.809
(0.115)
(0.115)
EBIT/Intx
3.973
0.124
0.106
Own earn%
(160.44)
(25.86)
(14.21)
Sh yield%
32.18
20.68
23.25
Owners
Insiders/Inst%
5.03
77.97
Short interest%
3.75
SBC / revenue%
1.97
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
23–32
$1 testx
0.2
Incr. ROIC%
16